Shuiying Hu Selected Research

Breast Neoplasms (Breast Cancer)

1/2021	Targeting OCT3 attenuates doxorubicin-induced cardiac injury.
1/2020	Ultra-thermostable RNA nanoparticles for solubilizing and high-yield loading of paclitaxel for breast cancer therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shuiying Hu Research Topics

Disease

19	Neoplasms (Cancer) 11/2022 - 08/2005
8	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2022 - 05/2008
6	Peripheral Nervous System Diseases (PNS Diseases) 12/2023 - 11/2019
3	Cardiotoxicity 01/2022 - 01/2018
2	Hyperalgesia 01/2023 - 01/2018
2	Colorectal Neoplasms (Colorectal Cancer) 11/2022 - 01/2020
2	Drug-Related Side Effects and Adverse Reactions 07/2022 - 01/2022
2	Leukemia 01/2021 - 05/2008
2	Breast Neoplasms (Breast Cancer) 01/2021 - 01/2020
2	Thyroid Neoplasms (Thyroid Cancer) 02/2007 - 01/2006
2	Papillary Thyroid Cancer 02/2007 - 02/2007
1	Prostatic Neoplasms (Prostate Cancer) 03/2024
1	Atrial Fibrillation 08/2022
1	Acute Kidney Injury (Acute Renal Failure) 11/2021
1	Hepatocellular Carcinoma (Hepatoma) 01/2020
1	Liver Neoplasms (Liver Cancer) 01/2020
1	Ovarian Neoplasms (Ovarian Cancer) 09/2019
1	Acute Megakaryoblastic Leukemia (Leukemia, Megakaryocytic) 01/2019
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 02/2014
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 08/2013
1	Thrombosis (Thrombus) 01/2013
1	Anorexia 01/2013
1	Neutropenia 01/2013
1	Lymphopenia (Lymphocytopenia) 01/2013
1	Exanthema (Rash) 01/2013
1	Glioma (Gliomas) 05/2008
1	Lung Injury 09/2007
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 09/2007
1	Anaplastic Thyroid Carcinoma 02/2007

Drug/Important Bio-Agent (IBA)

6	Paclitaxel (Taxol)FDA LinkGeneric 01/2021 - 01/2018
5	Sorafenib (BAY 43-9006)FDA Link 01/2020 - 05/2008
4	Vincristine (Oncovin)FDA LinkGeneric 12/2023 - 01/2021
4	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2021 - 06/2011
3	Oxaliplatin (Eloxatin)FDA LinkGeneric 11/2022 - 01/2020
3	NucleosidesIBA 01/2021 - 01/2017
3	Organic Cation Transporter 1IBA 01/2020 - 05/2008
3	Imatinib Mesylate (Gleevec)FDA Link 02/2014 - 05/2008
3	Phosphotransferases (Kinase)IBA 02/2014 - 06/2011
3	DNA (Deoxyribonucleic Acid)IBA 01/2006 - 08/2005
2	Biomarkers (Surrogate Marker)IBA 03/2024 - 11/2022
2	Docetaxel (Taxotere)FDA Link 03/2024 - 01/2021
2	Tyrosine Kinase InhibitorsIBA 10/2022 - 05/2008
2	Proteins (Proteins, Gene)FDA Link 07/2022 - 01/2020
2	Taxoids (Taxanes)IBA 02/2021 - 01/2021
1	Androgen Receptors (Androgen Receptor)IBA 03/2024
1	darolutamideIBA 03/2024
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 01/2024
1	AzolesIBA 12/2023
1	Ketoconazole (Nizoral)FDA LinkGeneric 12/2023
1	Cytochrome P-450 CYP3AIBA 12/2023
1	EnzymesIBA 12/2023
1	Duloxetine Hydrochloride (Cymbalta)FDA Link 11/2022
1	Cytochrome P-450 CYP3A InhibitorsIBA 10/2022
1	Itraconazole (Sporanox)FDA LinkGeneric 10/2022
1	gilteritinibIBA 10/2022
1	dofetilide (Tikosyn)FDA Link 08/2022
1	PotassiumIBA 08/2022
1	Membrane Transport Proteins (Biological Pump)IBA 01/2022
1	Carrier Proteins (Binding Protein)IBA 01/2022
1	Vinca AlkaloidsIBA 02/2021
1	Platinum Compounds (Compounds, Platinum)IBA 02/2021
1	Thalidomide (Thalomid)FDA Link 02/2021
1	Bortezomib (Velcade)FDA Link 02/2021
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021
1	nilotinib FDA Link 01/2021
1	CytidineIBA 01/2021
1	Calcium-Binding ProteinsIBA 01/2021
1	AlkaloidsIBA 01/2021
1	LigandsIBA 01/2020
1	Messenger RNA (mRNA)IBA 01/2020
1	RNA (Ribonucleic Acid)IBA 01/2020
1	LipidsIBA 09/2019
1	GlucuronidesIBA 01/2019
1	regorafenibIBA 01/2019
1	Janus Kinase InhibitorsIBA 01/2019
1	Peptides (Polypeptides)IBA 01/2019
1	UridineIBA 01/2019
1	AnionsIBA 01/2019
1	Glucuronosyltransferase (UDP Glucuronosyltransferase)IBA 01/2019
1	AnthracyclinesIBA 01/2018
1	XenobioticsIBA 01/2017
1	artenimol (dihydroartemisinin)IBA 01/2016
1	ArtesunateIBA 01/2016
1	ArtemisininsIBA 01/2016
1	crenolanibIBA 11/2013
1	Dasatinib (BMS 354825)FDA Link 08/2013
1	LuciferasesIBA 08/2013
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2013
1	Bevacizumab (Avastin)FDA Link 01/2013
1	Lipase (Acid Lipase)FDA Link 01/2013
1	Etoposide (VP 16)FDA LinkGeneric 04/2012
1	Acetylcarnitine (Alcar)IBA 04/2012
1	Carnitine (L-Carnitine)FDA LinkGeneric 04/2012
1	Sunitinib (Sutent)FDA Link 05/2008
1	Silicon Dioxide (Silica)FDA LinkGeneric 09/2007

Therapy/Procedure

9	Therapeutics 03/2024 - 01/2013
8	Drug Therapy (Chemotherapy) 01/2022 - 01/2016
1	Intravenous Injections 01/2020
1	Drug Tapering 01/2020
1	Intravenous Infusions 12/2019